NCT06304012

Effect of Oral Enteral Nutrition on Severe Traumatic Brain Injury

Name: Clinical Trial NCT06304012
Creator: Muhammad
Keywords: Traumatic Brain Injury, Nasogastric tube feeding, device, clinical trial, Taiwan

Oral Versus Nasal Enteral Nutrition on Severe Traumatic Brain Injury Patients With Tracheostomy: A Randomized Controlled Trial

Muhammad·ClinicalTrials.gov·device·Device trialCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Traumatic Brain Injury
Drug/Device/Intervention: Nasogastric tube feeding
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Muhammad
Funder: Ahmadu Bello University Teaching Hospital
Location: Yilan, Taiwan

Timeline & enrollment

Phase: N/A
Start date: Jun 01, 2022
End date: Jun 01, 2023
Enrollment: 104 participants

Primary outcome

Concentration of hemoglobin,Concentration of albumin,Concentration of prealbumin,Nutritional status-body mass index

Summary

This was a multicenter randomized controlled study of 98 severe Traumatic Brain Injury patients with tracheostomy. Patients enrolled were divided randomly into the observation group with Intermittent Oro-esophageal Tube Feeding (n=50) or the control group with Nasogastric tube feeding (n=48) for enteral nutrition support, respectively. Nutritional status, complications, decannulation of tracheostomy tubes and level of consciousness on day 1 and day 28 were recorded and compared.

ICD-10 classifications

Diffuse brain injuryIntracranial injuryFocal brain injuryIntracranial injury, unspecifiedOther intracranial injuries

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06304012
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06304012 through Pure Global AI's free database. This phase not specified trial is sponsored by Muhammad and is currently Completed. The study focuses on Traumatic Brain Injury. Target enrollment is 104 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.